Skip to content
Checked.be
Complete company report
Generated 16-08-2026
Active BE 0877.542.370Public limited company

SOLVAY PHARMACEUTICALS SA

Ransbeekstraat 310 ·1120 Brussel, Belgium· 20 yrs active
Sector: Activiteiten van hoofdkantoren (70100)
Conclusion Checked

The computed 12-month bankruptcy probability of SOLVAY PHARMACEUTICALS SA is 0.2% (very low). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 20 yrs
Board 4
Publications 14
Bankruptcy probability (12 mo) Checked model v1 · free
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Higher-failure-rate region +Long track record −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Long-established
Founded in 2005, 20 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 02-06-2026 2026-00135631
31-12-2024 volledig 19-06-2025 2025-00171150
31-12-2023 volledig 14-06-2024 2024-00135048
31-12-2022 volledig 09-06-2023 2023-00123480
31-12-2021 volledig 08-06-2022 2022-20055820
31-12-2020 volledig 07-06-2021 2021-18000055
31-12-2019 volledig 22-07-2020 2020-32800307
31-12-2018 volledig 11-06-2019 2019-17600255
31-12-2017 volledig 08-06-2018 2018-17700419
31-12-2016 volledig 06-06-2017 2017-15100438
Directors & mandates 16 directors
Current directors & mandates
  • Ernst & Young Réviseurs d'Entreprises SRLLegal entity
    Auditor
    State Gazette act 25102508 (12-08-2025)
    Current
    12-08-2025 → present
  • Emmanuel Vandevelde
    Director
    State Gazette act 24011885 (18-01-2024)
    Current
    18-01-2024 → present
  • Hugues Frisque
    Director
    State Gazette act 24011885 (18-01-2024)
    Current
    18-01-2024 → present
  • Michel Denayer
    Auditor
    State Gazette act 21088552 (23-07-2021)
    Current
    23-07-2018 → present
    2 events
    • 23-07-2021 Appointed· Auditor
    • 23-07-2018 Appointed· Auditor
Historic, not recently confirmed (4)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Louis d'Oreye
    Director
    State Gazette act 16158224 (18-11-2016)
    Not recently confirmed
    last confirmed in an act from 2016
    2 events
    • 18-11-2016 Appointed· Director
    • 18-11-2016 Appointed· Président du conseil d'administration
  • Deloitte
    Auditor
    State Gazette act 15082404 (11-06-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Christian Jourquin
    Director
    State Gazette act 06102267 (26-06-2006)
    Not recently confirmed
    last confirmed in an act from 2006
  • Coenraad Foppe de Graaf
    Director
    State Gazette act 06102267 (26-06-2006)
    Not recently confirmed
    last confirmed in an act from 2006
Permanent representatives (2)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • Eric Van Hoof
    Representant permanent
    State Gazette act 24138975 (26-09-2024)
    Permanent representative
    26-09-2024 → present
  • Marie Kaisin
    Representant permanent
    State Gazette act 24138975 (26-09-2024)
    Permanent representative
    - → 26-09-2024
Former directors (8)
  • Louis d'Oreye de Lantremange
    Administrator
    State Gazette act 22119524 (07-10-2022)
    Former
    07-10-2022 → 18-01-2024
    2 events
    • 18-01-2024 Resigned· Director
    • 07-10-2022 Appointed· Administrator
  • Mario Tondo
    Administrator
    State Gazette act 22119524 (07-10-2022)
    Former
    18-11-2016 → 18-01-2024
    4 events
    • 18-01-2024 Resigned· Director
    • 07-10-2022 Appointed· Administrator
    • 18-11-2016 Appointed· Director
    • 18-11-2016 Appointed· Managing director
  • Luc Lebrun
    Director
    State Gazette act 17088434 (23-06-2017)
    Former
    23-06-2017 → 06-10-2021
    2 events
    • 06-10-2021 Resigned· Director
    • 23-06-2017 Appointed· Director
  • Jean-Michel Detournay
    Director
    State Gazette act 16158224 (18-11-2016)
    Former
    - → 18-11-2016
  • Pascal Hubinont
    Director
    State Gazette act 16158224 (18-11-2016)
    Former
    - → 18-11-2016
3 further former directors in the mandate history. Available in Kantoor S. See plans →
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Statutory auditor 4 auditor
Statutory auditor IRE/IBR number Tenure
Ernst & Young Réviseurs d'Entreprises SRLCurrent
Commissaire
 - 07-10-2022 → present
Show 3 earlier auditors
Deloitte Réviseurs d'Entreprises SRL
Commissaire
 - - → 07-10-2022
Eric Nys
Commissaire
 - - → 23-06-2017
Michel Denayer
Commissaire
succeeded by Ernst & Young Réviseurs d'Entreprises SRL in 2022
 - 23-06-2017 → 07-10-2022
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Activiteiten van hoofdkantoren(70100)
Legal form Public limited company(014)
Incorporation28-11-2005
StatusActive
Postal code1120
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21819A0095/03B000 Brussels 1,224 m² - -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 24 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
02-06-2026
NBB filing Annual accounts filed
fiscal year 2025 · volledig
2025
12-08-2025
State Gazette act Director changes
v3.2
19-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
26-09-2024
State Gazette act Director changes
v3.2
14-06-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
18-01-2024
State Gazette act Director changes
v3.2
2023
19-06-2023
State Gazette act Statutes amendment
v3.2
09-06-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
07-10-2022
State Gazette act Director changes
v3.2
08-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
06-10-2021
State Gazette act Director changes
v3.2
23-07-2021
State Gazette act Director changes
v3.2
07-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
2020
22-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
15-10-2019
State Gazette act Capital & shares
v3.2
11-06-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
23-07-2018
State Gazette act Director changes
v3.2
08-06-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
23-06-2017
State Gazette act Director changes
v3.2
06-06-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
2016
18-11-2016
State Gazette act Director changes
v3.2
2015
11-06-2015
State Gazette act Director changes
v3.2
2010
23-11-2010
State Gazette act Director changes
v3.2
2006
26-06-2006
State Gazette act Statutes amendment
v3.2
Belgian State Gazette reading coverage 0 of 27 acts read

We know of 27 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 14 acts
Capital history · 1
15-10-2019
v3.2
All acts · 14 updated 1 year ago
2025
12-08-2025 Ernst & Young Réviseurs d'Entreprises SRL appointed as auditor Director changes
  • Ernst & Young Réviseurs d'Entreprises SRL, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Ernst \u0026 Young R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2024
26-09-2024 1 director appointed, 1 resigning Director changes
  • Eric Van Hoof, Representant permanent
  • Marie Kaisin, Representant permanent
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "representant permanent",
      "person": {
        "rrn": null,
        "name": "Eric Van Hoof",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "representant permanent",
      "person": {
        "rrn": null,
        "name": "Marie Kaisin",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
18-01-2024 2 directors appointed, 2 resigning Director changes
  • Hugues Frisque, Bestuurder
  • Emmanuel Vandevelde, Bestuurder
  • Mario Tondo, Bestuurder
  • Louis d'Oreye de Lantremange, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Mario Tondo",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Louis d\u0027Oreye de Lantremange",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Hugues Frisque",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Emmanuel Vandevelde",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2023
19-06-2023 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
2022
07-10-2022 3 directors appointed, 1 resigning Director changes
  • Louis d'Oreye de Lantremange, Administrator
  • Mario Tondo, Administrator
  • Ernst & Young Réviseurs d'Entreprises SRL, Commissaire
  • Deloitte Réviseurs d'Entreprises SRL, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Louis d\u0027Oreye de Lantremange",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Mario Tondo",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Deloitte R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Ernst \u0026 Young R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2021
06-10-2021 Luc Lebrun resigns as director Director changes
  • Luc Lebrun, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Luc Lebrun",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
23-07-2021 Michel Denayer appointed as auditor Director changes
  • Michel Denayer, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Michel Denayer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2019
15-10-2019 Capital decrease of €85,274,952.50 to €100,000 Capital & shares
  • €85.374.952,50 → €100.000
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 100000,
      "delta_eur": -85274952.5,
      "before_eur": 85374952.5,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2018
23-07-2018 Michel Denayer appointed as auditor Director changes
  • Michel Denayer, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Michel Denayer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2017
23-06-2017 2 directors appointed, 1 resigning Director changes
  • Luc Lebrun, Bestuurder
  • Michel Denayer, Commissaire
  • Eric Nys, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Luc Lebrun",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Eric Nys",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Michel Denayer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2016
18-11-2016 4 directors appointed, 2 resigning Director changes
  • Louis d'Oreye, Bestuurder
  • Louis d'Oreye, Président du conseil d'administration
  • Mario Tondo, Bestuurder
  • Mario Tondo, Gedelegeerd bestuurder
  • Pascal Hubinont, Bestuurder
  • Jean-Michel Detournay, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "Administrateur",
      "person": {
        "rrn": null,
        "name": "Louis d\u0027Oreye",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur",
      "person": {
        "rrn": null,
        "name": "Pascal Hubinont",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Pr\u00E9sident du conseil d\u0027administration",
      "person": {
        "rrn": null,
        "name": "Louis d\u0027Oreye",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Administrateur",
      "person": {
        "rrn": null,
        "name": "Mario Tondo",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur",
      "person": {
        "rrn": null,
        "name": "Jean-Michel Detournay",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Administrateur-d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Mario Tondo",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2015
11-06-2015 2 directors appointed Director changes
  • Deloitte, Auditor
  • Eric Nys, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Deloitte",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Eric Nys",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2010
23-11-2010 Juergen Enst resigns as director Director changes
  • Juergen Enst, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Juergen Enst",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  }
}
2006
26-06-2006 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0877.542.370",
    "name_full": "SOLVAY PHARMACEUTICALS SA"
  },
  "legal_form_change": {
    "new": "SOCIETE ANONYME",
    "old": "SOCIETE ANONYME",
    "changed": false
  }
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Activiteiten van hoofdkantoren70100Activiteiten van hoofdkantoren70100Coördinatiecentra74152
Primary activity highlighted.
Names & trade names
Legal nameFR SOLVAY PHARMACEUTICALS SA
Registered office
Ransbeekstraat 310
1120 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 1,104 of 5,600 with filed accounts
Audit & Risk Consultancy Johan Lambert BE 0744.502.417 · Brussel
CCLC Projets BE 1008.155.147 · Brussel
SOLVAY BE 0403.091.220 · Brussel
ACCOR HOTELS BELGIUM BE 0413.483.185 · Brussel
ADECCO COORDINATION CENTER BE 0441.164.215 · Dilbeek
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative